Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Astellas Pharma Inc |
---|---|
Information provided by: | Astellas Pharma Inc |
ClinicalTrials.gov Identifier: | NCT00818584 |
This study will evaluate pharmacokinetics and safety of intravenous micafungin in neonates with suspected candida infection
Condition | Intervention | Phase |
---|---|---|
Candida |
Drug: Micafungin |
Phase I |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Parallel Assignment, Pharmacokinetics Study |
Official Title: | A Phase 1 Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates |
Enrollment: | 13 |
Study Start Date: | August 2007 |
Study Completion Date: | October 2007 |
Primary Completion Date: | October 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1. micafungin lower dose: Experimental |
Drug: Micafungin
IV Administration
|
2. micafungin higher dose: Experimental |
Drug: Micafungin
IV Administration
|
Subjects will be stratified by weight to receive one of two doses of study drug
Ages Eligible for Study: | up to 120 Days |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Alabama | |
Birmingham, Alabama, United States, 35233 | |
United States, California | |
Orange, California, United States, 92868 | |
United States, Kentucky | |
Louisville, Kentucky, United States, 40202 | |
United States, Missouri | |
Kansas City, Missouri, United States, 64108 | |
United States, North Carolina | |
Durham, North Carolina, United States, 27710 | |
United States, Texas | |
Dallas, Texas, United States, 75390 | |
United States, Virginia | |
Charlottesville, Virginia, United States, 22908 |
Study Director: | Use Central Contact | Astellas Pharma US, Inc. |
Responsible Party: | Astellas Pharma US, Inc ( Sr Manager Clinical Trials Registry ) |
Study ID Numbers: | 9463-CL-2104 |
Study First Received: | January 6, 2009 |
Last Updated: | January 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00818584 |
Health Authority: | United States: Food and Drug Administration |
Micafungin Candida Neonates Mycamine FK463 |
Clotrimazole Miconazole Tioconazole Torulopsis Micafungin |
Anti-Infective Agents Therapeutic Uses Antifungal Agents Pharmacologic Actions |